331 related articles for article (PubMed ID: 32079701)
1. Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.
Bobillo S; Crespo M; Escudero L; Mayor R; Raheja P; Carpio C; Rubio-Perez C; Tazón-Vega B; Palacio C; Carabia J; Jiménez I; Nieto JC; Montoro J; Martínez-Ricarte F; Castellvi J; Simó M; Puigdefàbregas L; Abrisqueta P; Bosch F; Seoane J
Haematologica; 2021 Feb; 106(2):513-521. PubMed ID: 32079701
[TBL] [Abstract][Full Text] [Related]
2. Detection of the
Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
Front Oncol; 2018; 8():382. PubMed ID: 30294590
[TBL] [Abstract][Full Text] [Related]
3. Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.
Yoon SE; Kim YJ; Shim JH; Park D; Cho J; Ko YH; Park WY; Mun YC; Lee KE; Cho D; Kim WS; Kim SJ
Cancer Res Treat; 2022 Apr; 54(2):597-612. PubMed ID: 34325497
[TBL] [Abstract][Full Text] [Related]
4. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.
Shah M; Takayasu T; Zorofchian Moghadamtousi S; Arevalo O; Chen M; Lan C; Duose D; Hu P; Zhu JJ; Roy-Chowdhuri S; Riascos RF; Chen H; Luthra R; Esquenazi Y; Ballester LY
J Mol Diagn; 2021 Feb; 23(2):171-180. PubMed ID: 33531134
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
7. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma.
Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG
Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881
[TBL] [Abstract][Full Text] [Related]
9. Circulating Tumor DNA in Lymphoma.
Kambhampati S; Zain J
Curr Hematol Malig Rep; 2022 Dec; 17(6):298-305. PubMed ID: 36214943
[TBL] [Abstract][Full Text] [Related]
10. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
[TBL] [Abstract][Full Text] [Related]
11. Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
Miller AM; Karajannis MA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1363-1369. PubMed ID: 36509077
[TBL] [Abstract][Full Text] [Related]
12. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
[TBL] [Abstract][Full Text] [Related]
13. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM; Mattlener J; Schneider J; Gödel P; Sieg N; Ullrich F; Lewis R; Bucaciuc-Mracica T; Schwarz RF; Rueß D; Ruge MI; Montesinos-Rongen M; Deckert M; Blau T; Kutsch N; Balke-Want H; Weiss J; Becker K; Reinhardt HC; Hallek M; Borchmann P; von Tresckow B; Borchmann S
Blood; 2024 Feb; 143(6):522-534. PubMed ID: 37946299
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
[TBL] [Abstract][Full Text] [Related]
15. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma.
Duan H; Hu JL; Chen ZH; Li JH; He ZQ; Wang ZN; Zhang GH; Guo XY; Liang L; Mou YG
Chin Med J (Engl); 2020 Jun; 133(12):1415-1421. PubMed ID: 32558704
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour DNA in B-cell lymphomas: current state and future prospects.
Lakhotia R; Roschewski M
Br J Haematol; 2021 Jun; 193(5):867-881. PubMed ID: 33550600
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC.
Wu J; Liu Z; Huang T; Wang Y; Song MM; Song T; Long G; Zhang X; Li X; Zhang L
Mol Oncol; 2023 May; 17(5):810-824. PubMed ID: 36495130
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
Mutter JA; Alig SK; Esfahani MS; Lauer EM; Mitschke J; Kurtz DM; Kühn J; Bleul S; Olsen M; Liu CL; Jin MC; Macaulay CW; Neidert N; Volk T; Eisenblaetter M; Rauer S; Heiland DH; Finke J; Duyster J; Wehrle J; Prinz M; Illerhaus G; Reinacher PC; Schorb E; Diehn M; Alizadeh AA; Scherer F
J Clin Oncol; 2023 Mar; 41(9):1684-1694. PubMed ID: 36542815
[TBL] [Abstract][Full Text] [Related]
19. Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.
Olszewski AJ; Chorzalska AD; Petersen M; Ollila TA; Zayac A; Kurt H; Treaba DO; Reagan JL; Hsu A; Egan PC; Butera J; Niroula R; Vatkevich J; Robison J; Sahin I; Jacob AP; Mullins CD; Dubielecka PM
Blood Adv; 2021 Dec; 5(24):5525-5535. PubMed ID: 34551072
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.
Feng W; Jia N; Jiao H; Chen J; Chen Y; Zhang Y; Zhu M; Zhu C; Shen L; Long W
J Transl Med; 2021 Feb; 19(1):51. PubMed ID: 33536036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]